I think it has already been proven in a number of studies that the Bioavalilability of injectible v oral (Elmiron) is far superior (this is why compunding chemists are breaking down Elmiron and providing it in an injectible form. I would consequently take a guess to get the same effects as the injectible you would need to consume much more Oral which would then bring into play more issues with saftey etc. I think they will get some effect but no where near as good as what the injectiable form delivers.
Im sure the numbers man (aka Mozz) has a deep dive somewhere on this.
research reports and media, page-2022
-
- There are more pages in this discussion • 2,166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |